US · Healthcare · Medical Devices
EPS came in at 1.12 against a street estimate of 0.92 — a beat of 21.7%.
Analysts rate Globus Medical a buy (9 buy, 5 hold, 0 sell out of 14) with an average price target of $103.92.
| Fund | Stake |
|---|---|
| BlackRock Inc | 7.73% |
| HHG PLC | 5.62% |
| Vanguard Capital Management, LLC | 3.71% |
| Vanguard Portfolio Management, LLC | 3.59% |
| Amvescap Plc. | 3.18% |
| State Street Corp | 2.64% |
| OZ Management LLC | 2.25% |
| JPMorgan Chase & Co | 1.91% |
| Document | Date |
|---|---|
| Board / officer change · Q2 2026 | 2026-06-04 |
| Quarterly report · Q1 2026 | 2026-05-07 |
| Results announced · Q2 2026 | 2026-05-07 |
| Proxy statement · Q2 2026 | 2026-04-24 |
| Board / officer change · Q1 2026 | 2026-03-23 |
| Annual report FY2025 | 2026-02-24 |
| Results announced · Q1 2026 | 2026-02-24 |
| Quarterly report · Q3 2025 | 2025-11-06 |
Readable in the app.
| Announcement | Date |
|---|---|
| FY2025 preliminary results and FY2026 financial guidance provided Globus Medical, Inc. announced preliminary unaudited net sales results for Q4 2025 and the full fiscal year 2025 on January 7, 2026. The company also provided preliminary financial guidance | 2026-01-07 |
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Globus Medical — free to start.
Google PlayApp StoreData updated 2026-08-05.